Anavex Life Sciences Corp (AVXL)

[poguemahone]

Mayo:

Please do ask some hard questions. The CCs are a joke, with DM reading brief prepared remarks that often ignore pertinent updates on clinical programs and then “opening” the call to questions. What then follows is Soumit congratulating DM on “all the progress” and then asking some softball questions which provide minimal clarity to the company’s strategic plans.

After 10 years of attracting few new analysts, one would think DM would try a different approach to attract more interest in the company. I also dispute DM’s claim that the company has been transparent with shareholders. The one and only in-person interaction we could have this past year, the Annual Meeting, was relegated to a live-streaming event this year—very cowardly on Missling’s part.

I think DM has done an abysmal job as CEO, and am shocked the BOD has allowed him to remain in this capacity (nepotism at its finest). If this recent news from the EMA has highlighted anything, it is how detached our leadership is from the reality of getting a drug successfully through the approval process and to commercialization.

We need a major change in leadership—this ship is listing in heavy seas!